Newsroom
-
Mammoth Biosciences Named as an “Endpoints 11” Most Promising Startup of 2022
Business WireLearn More -
Mammoth Bioscience Develops SNP-Detecting CRISPR System for SARS-CoV-2 Variant Surveillance
GenomeWebLearn More -
Mammoth Biosciences looks to build next generation CRISPR Toolbox
The Science Advisory BoardLearn More -
The 30-year-old female founder at the forefront of a billion-dollar bet on CRISPR gene editing
CNBCLearn More -
Venture Investment in Crispr Gene Editing Spurs Innovation, Hunt for IP
Wall Street JournalLearn More -